Arcellx Inc (ACLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACLX | RARE | BHVN | ||
| Company | Arcellx Inc | Ultragenyx Pharmaceu | Biohaven Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 82.24 | 55.58 | 49.38 | ||
| High | 82.24 | 56.83 | 50.55 | ||
| Low | 79.42 | 55.13 | 47.64 | ||
| Last | 81.44 | 56.51 | 48.57 | ||
| Change | -2.07 | +0.96 | -1.40 | ||
| % Change | -2.48% | +1.73% | -2.80% | ||
| Volume | 427,000 | 507,500 | 2,479,400 | ||
| 20-Day Average Volume | 514,740 | 589,405 | 1,374,510 | ||
| Previous Close | 83.51 | 55.55 | 49.97 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 78.80 | 56.94 | 41.63 | ||
| 20-Day Raw Stochastic | 70.60% | 41.69% | 79.52% | ||
| 20-Day Relative Strength | 63.43% | 55.78% | 65.53% | ||
| Weighted Alpha | +94.40 | +61.13 | +88.47 | ||
| Today's Opinion | 100% Buy | 80% Buy | 40% Buy | ||
| Previous Opinion | 100% Buy | 80% Buy | 40% Buy | ||
| Last Month's Opinion | 88% Buy | 88% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.55% since 09/24/24 | -1.69% since 09/24/24 | +7.84% since 09/24/24 | ||
| Low | 79.42 on 10/01/24 | 53.75 on 09/30/24 | 45.65 on 09/25/24 | ||
| High | 86.40 on 09/30/24 | 57.78 on 09/25/24 | 51.99 on 09/26/24 | ||
| 1-Month | |||||
| %Chg | +18.48% since 08/30/24 | -0.48% since 08/30/24 | +23.27% since 08/30/24 | ||
| Low | 64.10 on 09/04/24 | 53.75 on 09/30/24 | 35.29 on 09/12/24 | ||
| High | 88.66 on 09/20/24 | 60.37 on 09/16/24 | 51.99 on 09/26/24 | ||
| 3-Month | |||||
| %Chg | +51.94% since 07/01/24 | +37.43% since 07/01/24 | +37.55% since 07/01/24 | ||
| Low | 49.00 on 08/05/24 | 39.65 on 07/05/24 | 32.50 on 08/05/24 | ||
| High | 88.66 on 09/20/24 | 60.37 on 09/16/24 | 51.99 on 09/26/24 | ||
| 6-Month | |||||
| %Chg | +21.59% since 04/01/24 | +20.31% since 04/01/24 | -6.70% since 04/01/24 | ||
| Low | 47.88 on 05/10/24 | 37.02 on 06/18/24 | 26.80 on 05/29/24 | ||
| High | 88.66 on 09/20/24 | 60.37 on 09/16/24 | 55.72 on 04/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,468,035 | 4,618,038 | 4,411,951 | ||
| Shares Outstanding, K | 53,503 | 83,133 | 88,292 | ||
| Annual Sales | 110,320,000 | 434,250,000 | 0 | ||
| Annual Net Income | -70,690,000 | -606,640,000 | -408,170,000 | ||
| Last Quarter Sales | 27,380,000 | 147,030,000 | 0 | ||
| Last Quarter Net Income | -27,200,000 | -131,600,000 | -319,770,000 | ||
| 60-Month Beta | 0.23 | 0.56 | 1.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.51 on 08/08/24 | -1.52 on 08/01/24 | -3.64 on 08/08/24 | ||
| Latest Earnings Date | 11/11/24 | 11/07/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||